Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Recipharm Pharmaceutical Development AB

Closing information (x1000 NOK)

Closing information 2023/12 2022/12 2021/12
Turnover 121,636 Less Arrow 88,403 More Arrow 97,722
Financial expenses 2,944 Less Arrow 1,530 Less Arrow 295
Earnings before taxes 9,882 Less Arrow -7,623 More Arrow -6,272
EBITDA 13,765 Less Arrow -4,300 More Arrow -2,537
Total assets 66,659 Less Arrow 46,368 More Arrow 61,814
Current assets 50,459 Less Arrow 29,237 More Arrow 45,827
Current liabilities 33,165 Less Arrow 20,931 More Arrow 29,204
Equity capital 33,494 Less Arrow 25,437 More Arrow 32,610
- share capital 51 Less Arrow 47 More Arrow 49
Employees (average) 69 Less Arrow 62 More Arrow 64

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 50.2% More Arrow 54.9% Less Arrow 52.8%
Turnover per employee 1,763 Less Arrow 1,426 More Arrow 1,527
Profit as a percentage of turnover 8.1% Less Arrow -8.6% More Arrow -6.4%
Return on assets (ROA) 19.2% Less Arrow -13.1% More Arrow -9.7%
Current ratio 152.1% Less Arrow 139.7% More Arrow 156.9%
Return on equity (ROE) 29.5% Less Arrow -30.0% More Arrow -19.2%
Change turnover 26,960 Less Arrow -6,382 More Arrow -3,531
Change turnover % 28% Less Arrow -7% More Arrow -3%
Chg. No. of employees 7 Less Arrow -2 More Arrow 3
Chg. No. of employees % 11% Less Arrow -3% More Arrow 5%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.